Replacing immune cells called microglia holds promise for addressing brain conditions such as Alzheimer’s disease.
News-Medical.Net on MSN
Genetic modification enhances "living drugs" for blood cancers
CAR T cells are patient-derived, genetically engineered immune cells. They are "living drugs" and constitute a milestone in modern medicine. Equipping T cells, a key cell type of the immune system, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results